Research map: Underexplored Ligand‐Binding Features of FabI From Staphylococcus aureus and Escherichia coli : A Comparative Pharmacophoric Modeling and Surface Mapping Approach

Back to the article

Papers in this map

  1. The Protein Data Bank · Helen Miriam Berman · 2000 · 40599 citations · Cited by this paper
  2. Fragmentation of Vancoresmycin Reveals a Strong Dependence on Global Molecular Architecture for Antibacterial Activity · 2026 · Related
  3. PLIP: fully automated protein–ligand interaction profiler · Sebastian Salentin · 2015 · 2428 citations · Cited by this paper
  4. Synthesis and Biological Activity of Novel Aromatic Aminopropyl Lactams in Two Cancer Cell Models · 2026 · Related
  5. Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database · Paul C. D. Hawkins · 2010 · 1699 citations · Cited by this paper
  6. A Priori Design, Combinatorial Synthesis, and Assessment of an Antipackaging Peptide Against Human Immunodeficiency Virus 1: Functional Role of Unnatural Trp Mimetics and Serendipitous Discovery of a Protease Inhibitor · 2026 · Related
  7. Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? · Marlieke E.A. de Kraker · 2016 · 1643 citations · Cited by this paper
  8. Novel Inhibitors of Carbonic Anhydrase I and II Identified by High Throughput Virtual Screening and Validated by X‐Ray Crystallography · 2026 · Related
  9. Comparison of Shape-Matching and Docking as Virtual Screening Tools · Paul C. D. Hawkins · 2006 · 1032 citations · Cited by this paper
  10. Molecular Hybridization of Clinically Relevant P2X7 Antagonists · 2026 · Related
  11. Evaluating Virtual Screening Methods: Good and Bad Metrics for the “Early Recognition” Problem · Jean‐François Truchon · 2007 · 896 citations · Cited by this paper
  12. Identification of a Class of Novel, Selective, Structurally Distinct GluN2A Negative Allosteric Modulators Through Virtual Screening · 2026 · Related
  13. THE STRUCTURAL BIOLOGY OF TYPE II FATTY ACID BIOSYNTHESIS · Stephen W. White · 2005 · 851 citations · Cited by this paper
  14. Furagin Derivatives—Nitrofuran‐Based Hydrazones as Potential Dual Inhibitors of Thioredoxin Reductase and Carbonic Anhydrases · 2026 · Related
  15. The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins · Dima Kozakov · 2015 · 695 citations · Cited by this paper
  16. Medicinal Chemistry of Agents for Cancer Therapy and Diagnosis From Uruguay · 2026 · Related
  17. Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis · Richard J. Heath · 1999 · 555 citations · Cited by this paper
  18. Design and Synthesis of Novel Isoflavene TANK‐Binding Kinase 1 Inhibitors With Anti‐Inflammatory Activity · 2026 · Related
  19. Molecular basis of triclosan activity · Colin Levy · 1999 · 518 citations · Cited by this paper
  20. Design and Synthesis of Novel Imidazo[4,5‐ c ]pyridine Derivatives, Evaluation of Their Activity Against Hepatitis C Virus and In Silico Prediction of Their Binding Mode to NS4B Protein · 2026 · Related
  21. A Mechanism of Drug Action Revealed by Structural Studies of Enoyl Reductase · Clair Baldock · 1996 · 246 citations · Cited by this paper
  22. Structural basis and mechanism of enoyl reductase inhibition by triclosan · Michael J. Stewart · 1999 · 225 citations · Cited by this paper
  23. Pharmacophore-Based Virtual Screening · Hongmao Sun · 2008 · 179 citations · Cited by this paper
  24. Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK · Mark A. Seefeld · 2003 · 163 citations · Cited by this paper
  25. Kinetic and Structural Characteristics of the Inhibition of Enoyl (Acyl Carrier Protein) Reductase by Triclosan · Walter H.J. Ward · 1999 · 162 citations · Cited by this paper
  26. Mechanistic diversity and regulation of Type II fatty acid synthesis · Hédia Marrakchi · 2002 · 135 citations · Cited by this paper
  27. Identification of potential inhibitors for LLM of Staphylococcus aureus : structure-based pharmacophore modeling, molecular dynamics, and binding free energy studies · Reena Kumari · 2021 · 126 citations · Cited by this paper
  28. Molecular basis for triclosan activity involves a flipping loop in the active site · Xiayang Qiu · 1999 · 116 citations · Cited by this paper
  29. Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI) · William H. Miller · 2002 · 113 citations · Cited by this paper
  30. Staphylococcus aureus FabI: Inhibition, Substrate Recognition, and Potential Implications for In Vivo Essentiality · Johannes Schiebel · 2012 · 95 citations · Cited by this paper
  31. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors · Preeti Rana · 2020 · 71 citations · Cited by this paper
  32. Discovery of a Novel and Potent Class of F. tularensis Enoyl-Reductase (FabI) Inhibitors by Molecular Shape and Electrostatic Matching · Kirk E. Hevener · 2011 · 69 citations · Cited by this paper
  33. Mechanism and Inhibition of saFabI, the Enoyl Reductase fromStaphylococcus aureus · Hua Xu · 2008 · 66 citations · Cited by this paper
  34. Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase Inhibitor · Johannes Schiebel · 2014 · 65 citations · Cited by this paper
  35. Structural insights into Staphylococcus aureus enoyl‐ACP reductase (FabI), in complex with NADP and triclosan · Amit Priyadarshi · 2009 · 57 citations · Cited by this paper
  36. Resistance to AFN-1252 Arises from Missense Mutations in Staphylococcus aureus Enoyl-acyl Carrier Protein Reductase (FabI) · Jiangwei Yao · 2013 · 51 citations · Cited by this paper
  37. Benzimidazole-Based FabI Inhibitors: A Promising Novel Scaffold for Anti-staphylococcal Drug Development · Tina L. Mistry · 2016 · 36 citations · Cited by this paper
  38. An Ordered Water Channel in Staphylococcus aureus FabI: Unraveling the Mechanism of Substrate Recognition and Reduction · Johannes Schiebel · 2015 · 32 citations · Cited by this paper
  39. The Kalimantacin Polyketide Antibiotics Inhibit Fatty Acid Biosynthesis in Staphylococcus aureus by Targeting the Enoyl‐Acyl Carrier Protein Binding Site of FabI · Christopher D. Fage · 2020 · 32 citations · Cited by this paper

Source: OpenAlex (CC0)